GRALVSSLS• 12 Months (Normalized)
GRAL vs SLS (GRAIL Inc. vs SELLAS Life Sciences Group Inc.)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GRAL Performance $136.57
+130.97%
GRAIL Inc.
Normalized Baseline0.00%
SLS Performance $11.52
+%
SELLAS Life Sciences Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin GRAL LEADS
+130.97 pts
GRAL outperforming by 130.97 percentage points
GRALSLS
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GRAL SLS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GRAL Price | GRAL Gain (%) | SLS Price | SLS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $136.57 | +130.97% | $- | - | |
| Sep 28, 2026 | $132.63 | +124.30% | $- | - | |
| Sep 25, 2026 | $126.89 | +114.59% | $- | - | |
| Sep 24, 2026 | $125.21 | +111.75% | $- | - | |
| Sep 23, 2026 | $108.52 | +83.53% | $11.52 | +615.53% | -532.00% |
| Sep 22, 2026 | $108.52 | +83.53% | $12.02 | +646.58% | -563.05% |
| Sep 21, 2026 | $107.97 | +82.60% | $11.37 | +606.21% | -523.61% |
| Sep 18, 2026 | $80.77 | +36.60% | $11.49 | +613.66% | -577.06% |
| Sep 17, 2026 | $79.95 | +35.21% | $11.53 | +616.15% | -580.94% |
| Sep 16, 2026 | $75.11 | +27.03% | $11.66 | +624.22% | -597.19% |
| Sep 15, 2026 | $75.89 | +28.34% | $11.29 | +601.24% | -572.90% |
| Sep 14, 2026 | $75.53 | +27.74% | $11.73 | +628.57% | -600.83% |
| Sep 11, 2026 | $76.23 | +28.92% | $11.55 | +617.39% | -588.47% |
| Sep 10, 2026 | $77.56 | +31.17% | $13.49 | +737.89% | -706.72% |
| Sep 09, 2026 | $77.48 | +31.03% | $13.95 | +766.46% | -735.43% |
Page 1 of 17